Keratoconus: treatment

Keratoconus is a progressive eye disease that starts near the collagen fibres, i.e. the cornea, causing the normally round cornea to thin and change from a spherical to a cone-like shape.

  • Stabilising keratoconus
  • Improved vision

What is keratoconus?

The cornea is the transparent front part of the eye that refracts light. A normal cornea is shaped like a perfectly round ball and consists of collagen fibres which give the cornea its structure and firmness.

Keratoconus is a progressive eye disease that starts near these collagen fibres, i.e. the cornea, causing the normally round cornea to thin and change from a spherical to a cone-like shape.

This progressive thinning of the cornea leads to a bulging with irregular astigmatism (oval eye) and worsening myopia (short-sightedness). In most cases (80-90 %), both eyes are affected, but a difference in severity between both eyes is common (bilateral asymmetric disorder). Keratoconus usually develops from puberty up to the age of about 45 and is more common in men than in women.

What are the symptoms of Keratoconus?

Keratoconus is difficult to diagnose because it develops slowly. Possible symptoms are:

  • Distorted and reduced vision, like looking into a fun house mirror
  • Hypersensitivity to light
  • Change in the strength of glasses and/or lenses
  • Itchy eyes
  • Frequent rubbing of the eyes
  • Double vision if one eye is covered

Causes of keratoconus

The true cause of keratoconus is unknown. Probably several factors play a role: hereditary (10 %) and environmental.

Other possible causes could be:

  • Regular rubbing of the eyes, especially in people who suffer from an eye allergy
  • Physical disorders, e.g. Down’s and Turner syndromes, osteogenesis imperfecta, atopic eczema, connective tissue disease…
  • Ophthalmic disorders
  • Refractive surgery

How do we treat keratoconus?

Initially, keratoconus can be treated with corrective lenses or (semi) hard contact lenses, but, as time goes by, patients can develop a progressive intolerance to lenses. Corneal transplant used to be the treatment of choice if the condition degenerated but the risk of subsequent complications was high.

Recently, a new technology was developed that halts the corneal thinning process – Ultraviolet Cross-linking, and a method to normalise the shape of the cornea, i.e. intracorneal ring segments.

Ultraviolet Crosslink

Keratoconus is characterised by reduced cross-links between the collagen fibres which ultimately reduces corneal strength.

Ultraviolet Crosslink is a new technique. The objective of this treatment is to strengthen the collagen structures in the central part of the cornea by creating new connections between the collagen fibres. This increases the strength and stability of the cornea and flattens the central, weaker, thinner area. Short-sightedness and astigmatism will improve as a result. This treatment is not suitable for patients with advanced keratoconus.


A photosensitive fluid (riboflavin) is administered to the cornea which penetrates into the deeper layers of the cornea. The cornea is then irradiated with ultraviolet-A light, creating extra connections between the collagen fibres and thickening the collagen fibres. The collagen fibres become three times stronger and this process stabilises after 6 months. As the cornea flattens out and becomes less pointed, vision can improve. This treatment can halt the progression of keratoconus during the progressive phase.


While this treatment used to take over an hour (30 minutes for the eye drops, 30 minutes for UV), the AVEDRO technology has reduced it to a maximum of 20 minutes for the eye drops and to just 4 minutes for UV radiation. This is mainly due to a change in the eye drops and the higher energy of the UV source.

An additional advantage is that therapy can now be performed via the transepithelial route, so patients do not experience any post-operative pain.

Refractive abnormalities (myopia, irregular astigmatism) are treated beforehand with lasers (the topo-guided excimer laser) or afterwards by phaco with toric intraocular lenses.

When is this treatment indicated?

To prevent the development of keratoconus

  • To treat progressive keratoconus
  • To treat corneal ectasia (bulging)
  • To address corneal instability after radial keratotomy (i.e. incisions into the eye to correct short-sightedness)
  • In the case of chronic corneal oedema (swelling) and a resistant cornea ulcer (sore)
  • For recurrent keratoconus after corneal transplant surgery


Possible risks associated with this procedure are slow wound healing, abnormal wound healing (this risk is lower with AVEDRO technology) and post-operative infections.

Who is not eligible?

In patients with a corneal thickness of < 325 µm, with epithelial healing disorders, herpes keratitis and during pregnancy.

Intracorneal ring segments (Intacts)


Intracorneal ring segments (corneal implants) can be used when people cannot tolerate contact lenses or to postpone corneal transplant surgery. This outpatient treatment involves placing 1 or 2 semi-circular rings into the outer edges of the cornea under local anaesthetic. These cause the central, thinner part of the cornea to flatten out again, significantly reducing myopia and astigmatism. The rings also support the weaker, bulging part of the cornea.

This technique, which has been used for more than 15 years, recently gained momentum once again when the corneal tunnel incision that was previously carried out by means of surgical blades can now be performed with more precision using a laser device (Ziemer). The irregular shape of the cornea is corrected, markedly enhancing the patient’s quality of life.

In about 10 % of cases the intracorneal ring segments need to be adjusted.


Possible complications include ring displacement and post-operative infections; however, these are easily treated if detected at an early stage. After surgery, some patients may experience short-term irritation, light halos and photophobia.

Corneal transplantation

When the above treatments are no longer viable, corneal transplantation will be considered. If, as keratoconus progresses, patients can no longer tolerate contact lenses, a corneal transplantation can provide relief. Approximately 20 % of keratoconus patients will eventually reach this stage.

Keratoconus: treatment

1 eye
Keratoconus: treatment €1000


Dr. AL SABAI Nashwan

Dr. EVENS Peter

Dr. PION Bart



Dr. GREANT Philippe

Dr. RAHALI Majdaline

FEC 26

Personal advice from our experts

Our highly specialised surgeons thoroughly examine your eyes and make a detailed diagnosis. They discuss all the options with you in all objectivity.

FEC 26

Multidisciplinary team of experienced topsurgeons

All the knowledge in-house for a wide range of eye treatments. Meet the team

Meet the team
FEC 34

Personalised eye care

Each eye has its own unique profile, just like your fingerprints. This is why we apply the ultra-personalised topo-guided technique.

FEC 54

High-tech equipment

We continuously invest in the latest, most reliable technology. We have the most comprehensive and modern technological platform for laser eye treatment and lens surgery.

About our eye lens technology
FEC 13

A comfortable and pleasant setting

Our laser centre combines experts in their field with a warm welcome in a stylish setting so that you get to have your treatment in all peace and comfort.



We beantwoorden ze graag!